// App-Quantinova.ai

2427 : Polycomb group protein BMI1 protects neuroblastoma cells from DNA damage-induced apoptotic death in cooperation with L3MBTL2

Researchers

Presenter

  • Nobuhiro Akita

Principal Investigators

  • Hisanori Takenobu

  • Hiroshi Chikaraishi

  • Miki Ohira

  • Takehiko Kamijo

Medical Centers

  • RIKEN Research Center for Allergy and Immunology, Tsurumi-ku, Yokohama City, Japan

  • Research Institute for Clinical Oncology, Saitama Cancer Center, Kita-Adahi-Gun, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

  • Solid malignancies

Biomarkers

  • MYCN proto-oncogene, bHLH transcription factor

  • Polycomb complex protein

  • Polycomb-group

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved